Trial intelligence / Profile preview

Ultracet for Acute Migraine Treatment

NCT00297375Phase 4Completed

Sponsor
Johnson & Johnson
Start
Apr 2003
Modality
Small Molecules
01

Overview

A Phase 4 trial of tramadol in migraine, sponsored by Johnson & Johnson. Started Apr 2003; status: completed.

02

Drugs

tramadol
03

Conditions

migraine

Beyond the preview

Go deeper on NCT00297375.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00297375.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call